The relationship between mutation carriage of BRCA1/2 and clinicopathological characteristics in women with breast cancer – experience from a diagnostic centre in Turkey
dc.contributor.author | Duzkale, Neslihan | |
dc.contributor.author | Guler, Onur Can | |
dc.contributor.author | Kutun, Suat | |
dc.contributor.author | Emiroglu, Canan | |
dc.contributor.author | Saridemir, Serdar | |
dc.contributor.author | Gokce, Aysun | |
dc.contributor.author | Kandemir, Olcay | |
dc.date.accessioned | 2025-01-21T16:28:57Z | |
dc.date.available | 2025-01-21T16:28:57Z | |
dc.date.issued | 2024 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description.abstract | The 5–10% of breast cancers (BC) are hereditary, and BRCA1/2 are causative in 25% of those inherited. It was aimed to examine the BRCA1/2 genotype-BC phenotype relationship. In 170 female patients with BC, BRCA1/2 genes were investigated using Next Generation Sequencing. Demographic and clinicopathological characteristics of the patients and correlations of pedigree analysis with BRCA1/2 mutation status were analysed. BRCA1/2 carriage was found to be 9.4%. When the patients were grouped as ? 40 and > 40 according to the age at diagnosis of BC, the tumour grade was higher in the ? 40 groups. In the study, BRCA1/2 carriage and tumour grade were higher in patients with triple-negative breast cancers (TNBC). The risk of TNBC was 5.560 times higher in BRCA1/2 carriers than in non-carriers. There is a significant relationship between BRCA1/2 carrier and BC hormone receptor negativity, tumour grade, and BC diagnosis age. © 2024, Termedia Publishing House Ltd.. All rights reserved. | |
dc.identifier.doi | 10.5114/pjp.2024.142750 | |
dc.identifier.endpage | 204 | |
dc.identifier.issn | 1233-9687 | |
dc.identifier.issue | 3 | |
dc.identifier.pmid | 39451174 | |
dc.identifier.scopus | 2-s2.0-85207363324 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 192 | |
dc.identifier.uri | https://doi.org/10.5114/pjp.2024.142750 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/23658 | |
dc.identifier.volume | 75 | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Termedia Publishing House Ltd. | |
dc.relation.ispartof | Polish Journal of Pathology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_20241229 | |
dc.subject | BRCA1; BRCA2; breast cancer; oestrogen receptor; progesterone receptor; triple-negative | |
dc.title | The relationship between mutation carriage of BRCA1/2 and clinicopathological characteristics in women with breast cancer – experience from a diagnostic centre in Turkey | |
dc.type | Article |